{
    "clinical_study": {
        "@rank": "126305", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Determine the therapeutic efficacy and safety of topical calcitriol in children with\n      psoriasis."
        }, 
        "brief_title": "Study of Topical Calcitriol in Children With Psoriasis", 
        "completion_date": "July 2000", 
        "condition": "Psoriasis", 
        "condition_browse": {
            "mesh_term": "Psoriasis"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Patients apply topical calcitriol in petrolatum on a psoriatic lesion\n      daily. Patients also apply petrolatum without calcitriol to another psoriatic lesion daily.\n\n      Patients have both lesions photographed prior to therapy, monthly during therapy, and at the\n      completion of therapy.  Lesions are assessed weekly for 1 month and then every 2 weeks while\n      on study.  Blood samples are collected every 1 to 2 months and urine samples are collected\n      every 2 weeks while on study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Diagnosis of psoriasis At least 2 lesions with area at least 30-50 cm2\n\n        --Prior/Concurrent Therapy--\n\n        No other concurrent therapy for psoriasis No concurrent calcium supplements greater than\n        1,000 mg/day No concurrent prednisone or other drugs affecting serum or urine calcium\n        levels\n\n        --Patient Characteristics--\n\n        Renal: No high blood or urinary calcium levels\n\n        Other: Not pregnant Negative pregnancy test Fertile patients must use effective\n        contraception"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "September 11, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00006275", 
            "org_study_id": "199/15372", 
            "secondary_id": "BUSM-90-106"
        }, 
        "intervention": {
            "intervention_name": "calcitriol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Calcitriol"
        }, 
        "keyword": [
            "dermatologic disorders", 
            "psoriasis", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Boston University", 
            "last_name": "Michael F. Holick", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00006275"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Boston University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 2000", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2000"
    }, 
    "geocoordinates": {}
}